Speciality: Pediatrics
Description:
A warm welcome to all the medical professionals in this interesting session on Update on Growth Disorders
Recent advancements in the understanding and management of growth disorders have significantly improved outcomes for affected children. Growth disorders, such as growth hormone deficiency (GHD), Turner syndrome, and idiopathic short stature (ISS), often require early diagnosis and intervention for optimal growth and development. The use of recombinant human growth hormone (rhGH) therapy has been a cornerstone in treating many of these conditions, demonstrating substantial benefits in promoting height gain and improving overall health.
Genetic and molecular research has expanded knowledge of the underlying causes of various growth disorders, leading to more precise diagnostic tools and personalized treatment approaches. Innovations in genetic testing can now identify specific mutations responsible for growth impairments, allowing for targeted therapies that address the root causes. Additionally, emerging treatments, such as growth hormone secretagogues and insulin-like growth factor-1 (IGF-1) therapy, offer new avenues for managing growth disorders. Ongoing clinical trials and research continue to refine these therapies, aiming to enhance efficacy and minimize side effects, ultimately improving the quality of life for children with growth disorders.
Therefore, get an overall knowledge of update on growth disorders
See More Webinars @ Hidoc Webinars
1.
According to a study, breast cancer in Syrian refugees tends to be diagnosed at an earlier stage and with more advanced tumors.
2.
A prostate cancer risk prediction algorithm could help target men at highest risk
3.
The way that miR-377 inhibits cells that cause prostate cancer.
4.
In Advanced Myxoid Liposarcoma, Is Trabectedin Winning?
5.
Study indicates that exercise can help colon cancer survivors live as long as matched individuals
1.
A Review on Genetic Predispositions and Clinical Advancements of Multiple Myeloma Cancer
2.
AI-Powered Strategies for Precision and Improved Outcomes in Esophageal Cancer, a Global Health Crisis
3.
Claudin-18.2 in Gastric Cancer: Tumor-Stroma Crosstalk and Disease Progression
4.
Cracking the Code of Subdural Hematomas: Modern Strategies for Optimal Care
5.
The Benefits and Risks of Transurethral Resection of Bladder Tumor
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Efficient Management of First line ALK-rearranged NSCLC
2.
Newer Immunotherapies for Myeloma- A Comprehensive Overview- Part II
3.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
4.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV
5.
Oropharyngeal Cancer in Relation to HPV Status
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation